Kolexia
Barrie-Attarian Maryline
Neurologie
Hôpital La Timone
Marseille, France
93 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Gliome Glioblastome Tumeurs du cerveau Lymphomes Récidive tumorale locale Tumeurs du système nerveux central Névrite du plexus brachial Névrite Méningiome

Industries

B3TSI
5 collaboration(s)
Dernière en 2023
EXAFIELD
2 collaboration(s)
Dernière en 2023
IQVIA
2 collaboration(s)
Dernière en 2020
Servier
1 collaboration(s)
Dernière en 2023

Dernières activités

StrateGlio: Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Essai Clinique (Centre Oscar-Lambret)   08 février 2024
Prognostic value of Beta 2-Microglobulinin in cerebrospinal fluid in primary central nervous system lymphoma.
Journal of the neurological sciences   18 décembre 2023
Primary central nervous system lymphoma with initial spinal cord involvement (PCNSL-SC) is a rare entity: 4 case reports and review of literature
Revue neurologique   26 octobre 2023
546P Early urinary potassium level is predictive of delayed methotrexate (MTX) elimination in patients with primary central nervous system lymphoma (PCNSL)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
CAR-T CELLS RADICALLY MODIFY THE MANAGEMENT OF RELAPSED/REFRACTORY PRIMARY CEREBRAL LYMPHOMAS. REAL LIFE RESULTS OF THE FRENCH LOC NETWORK
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Radio-chemotherapy feasibility for biopsy-only unresectable wild-type glioblastomas (BO-GBM).
Neuro-oncology practice   30 mai 2023
Efficacy of CAR-T Cells in Primary Central Nervous System Lymphomas: The French Experience of the National LOC Network
Annual Meeting Abstracts 2022   15 novembre 2022
Prognostic value of circulating lymphocyte subsets in primary central nervous system lymphoma.
Journal of neuro-oncology   28 juin 2022
Urinary potassium and association with methotrexate (MTX) elimination delay in patients with primary central nervous system lymphoma (PCNSL).
2022 ASCO Annual Meeting I   02 juin 2022
iLOC: Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma
Essai Clinique (The Lymphoma Academic Research Organisation)   06 avril 2022